Back to Authors

Lipton, Richard B.

https://orcid.org/0000-0003-2652-2897

A5000448269 | I129975664

Mayo Clinic

Albert Einstein College of Medicine

Citations 145

Assessing Unmet Treatment Needs and Associated Disability in Persons With Migraine: Results from Migraine in America Symptoms and Treatment (MAST) Study (P3.10-003)

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p3.10-003

Impact of Migraine Headache Day Frequency on Associated Health: Results from the 2017 Migraine in America Symptoms and Treatment (MAST) Study (P3.10-001)

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p3.10-001

Efficacy of Erenumab in Chronic Migraine Patients With and Without Allodynia (P2.10-025)

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p2.10-025

Early and Sustained Effect of OnabotulinumtoxinA for Chronic Migraine Treatment: Pooled Analysis of PREEMPT Data (P2.10-018)

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p2.10-018

Improved Functionality, Pain Relief, and Satisfaction in Patients Treated With Ubrogepant vs Placebo: Results from 2 Single-Attack Phase 3 Studies, ACHIEVE I and II (P2.10-012)

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p2.10-012

Vascular Pathology Is Associated with Rate of Cognitive Decline Independent of AD Pathology (Einstein Aging Study) (P6.222)

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.p6.222

Perspectives of Adolescents/Young Adults on the Burden of Their Parent’s Migraine: Results from the CaMEO Study (P4.121)

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.p4.121

A Multicenter, Prospective, Single Arm, Open Label, Post-Market, Observational Study to evaluate the use of sTMS in reduction of Migraine Headache (ESPOUSE Study) (S52.004)

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.s52.004

Randomized, Double-blind, Placebo-controlled Trial of ALD403, an anti-CGRP peptide antibody in the prevention of chronic migraine. (S52.003)

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.s52.003

75% responder rates provide improvement in HIT-6 scores from week 4 through 12 following a single infusion of ALD403, or placebo. (P2.165)

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.p2.165